SHL Telemedicine (SHL Telemedicine) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is SHL Telemedicine ROE % Adjusted to Book Value?

SHL Telemedicine's ROE % for the quarter that ended in Dec. 2023 was -13.16%. SHL Telemedicine's PB Ratio for the quarter that ended in Dec. 2023 was N/A. SHL Telemedicine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.

SHL Telemedicine ROE % Adjusted to Book Value Historical Data

The historical data trend for SHL Telemedicine's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SHL Telemedicine ROE % Adjusted to Book Value Chart

SHL Telemedicine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

8.24

0.33

-8.71

SHL Telemedicine Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-3.90	0.02	-	-	-

Competitive Comparison of SHL Telemedicine's ROE % Adjusted to Book Value

For the Health Information Services subindustry, SHL Telemedicine's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SHL Telemedicine's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's ROE % Adjusted to Book Value falls into.

SHL Telemedicine ROE % Adjusted to Book Value Calculation

SHL Telemedicine's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-10.92%	/	N/A
	=	N/A

SHL Telemedicine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-13.16%	/	N/A
	=	N/A

SHL Telemedicine ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of SHL Telemedicine's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

SHL Telemedicine (SHL Telemedicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SHL Telemedicine Ltd (OTCPK:SMDCF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

SHLT:USA SHLTN:Switzerland

Address

90 Yigal Alon Street, Tel Aviv, ISR, 67891

Website

https://www.shl-telemedicine.com

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world.